Vazkepa TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: icosapent ethyl
Brand name
(ARTG)
: VAZKEPA icosapent ethyl 998 mg soft capsule bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
VAZKEPA is indicated to reduce the risk of cardiovascular events in adult statin-treated patients at high cardiovascular risk with elevated triglycerides (greater than or equal to 1.7 mmol/L) and, established cardiovascular disease, or, diabetes, and at least one other cardiovascular risk factor.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, soft
- Oral
- Oblong soft capsule, 25 x 10 mm, printed with IPE in white ink, with a light yellow to amber shell containing a colourless to pale yellow liquid.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Keep Container Tightly Closed/Airtight
- Protect from Moisture
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 120 pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
